However, Gal-3 can be considered as an indicator of prognosis, mortality or remission in neurodegenerative diseases [140] since its expression was found to be increased in patients with ALS, Alzheimer’s and Parkinson’s diseases (AD and PD, respectively) [141]. The gene discussed is LGALS3; the disease is Parkinson disease.